Inventiva

Advertisement

cGxPJobs Banner

Inventiva Completes Phase 3 NATiV3 Trial of Lanifibranor in MASH

Daix, France and New York, September 2, 2026 Inventiva announced that the last patient has completed the final 72-week...

By cGxPwire Editor
September 3, 2026

Read More

Advertisement

cGxPJobs

Directory